AccuVein Stock
AccuVein develops products that aid in the visualization of peripheral vasculature.
Sign up today and learn more about AccuVein Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About AccuVein Stock
AccuVein specializes in vein visualization technology. Its flagship product, the AV400, is a hand-held, non-contact vein illumination solution. It allows healthcare professionals to see a map of peripheral veins on the skin’s surface with the goal of accessing or avoiding veins. It is built on proprietary technology as embodied in its growing patent portfolio that covers a broad range of imaging and medical diagnostic technologies. The company was founded in 2006 and is headquartered in Medford, New York.
Funding History
July 2011 | $22.5M |
---|---|
February 2014 | $8.0M |
February 2018 | $8.0M |
September 2020 | $17.3M |
Management
Director
James D. Lackie
Director
Jimmy Lackie
VP Engineering and Operations
Joe Zott
President & CEO
Chris Hutchison
VP Marketing
Vinny Luciano
Press
globenewswire - Dec, 23 2023
[Latest] Healthcare Augmented and Virtual Reality Market Size ...pharmiweb - Dec, 23 2023
The Vein Finder Market is expected to register significant ...scoop - Dec, 23 2023
Augmented Reality Statistics: Impact of AR in Technological ...prweb - Jun, 10 2020
AccuVein Inc. Announces Appointment of Chris Hutchison, CEO and President